It is sometimes used in severe cases of oligohydramnios to prevent umbilical cord compression. However, there is uncertainty about the procedure's safety and efficacy, and it is recommended that it should only be performed in centres specialising in invasive fetal medicine and in the context of a multidisciplinary team.
- Fraser WD, Hofmeyr J, Lede R, et al. (September 2005). "Amnioinfusion for the prevention of the meconium aspiration syndrome". N. Engl. J. Med. 353 (9): 909–17. doi:10.1056/NEJMoa050223. PMID 16135835.
- Edwards RK, Duff P (1999). "Prophylactic cefazolin in amnioinfusions administered for meconium-stained amniotic fluid". Infect Dis Obstet Gynecol 7 (3): 153–7. doi:10.1155/S1064744999000241. PMC 1784731. PMID 10371474.
- Hsu TL, Hsu TY, Tsai CC, Ou CY (December 2007). "The experience of amnioinfusion for oligohydramnios during the early second trimester". Taiwan J Obstet Gynecol 46 (4): 395–8. doi:10.1016/S1028-4559(08)60009-1. PMID 18182345.
- Oligohydramnios at the National Institute for Health and Clinical Excellence. Based on the overview Therapeutic amnioinfusion for oligohydramnios during pregnancy (excluding labour) in 2006
|This medical treatment–related article is a stub. You can help Wikipedia by expanding it.|